Literature DB >> 24295723

"Methylene blue should be relegated to rescue use and not as first-line therapy" cannot become a paradigm.

Paulo R B Evora1, Alfredo José Rodrigues1, Andrea C Celotto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24295723     DOI： 10.1053/j.jvca.2013.09.009

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  5 in total

1.  "Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock.

Authors:  Paulo Roberto B Evora; Domingo M Braile
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

2.  Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.

Authors:  J Hunter Mehaffey; Lily E Johnston; Robert B Hawkins; Eric J Charles; Leora Yarboro; John A Kern; Gorav Ailawadi; Irving L Kron; Ravi K Ghanta
Journal:  Ann Thorac Surg       Date:  2017-05-24       Impact factor: 4.330

3.  A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.

Authors:  Rachel Erin Graham; Michaela Cartner; James Winearls
Journal:  BMJ Case Rep       Date:  2015-07-06

Review 4.  Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.

Authors:  Paulo Roberto Barbosa Evora; Lafaiete Alves Junior; Cesar Augusto Ferreira; Antônio Carlos Menardi; Solange Bassetto; Alfredo José Rodrigues; Adilson Scorzoni Filho; Walter Vilella de Andrade Vicente
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jan-Mar

5.  Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery.

Authors:  Aly Makram Habib; Ahmed Galal Elsherbeny; Rayd Abdelaziz Almehizia
Journal:  Indian J Crit Care Med       Date:  2018-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.